⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Serine SCHEMBL28461676 | 1.00 | — | — | |
| Serine SCHEMBL28890324 | 0.97 | SLC1A1 (0.54) | — | |
| Serine SCHEMBL6520912 | 0.97 | SLC1A1 (0.59) | — | |
| Serine SCHEMBL6929773 | 0.97 | SLC1A1 (0.59) | — | |
| (D)-Serine SCHEMBL6038168 | 0.97 | SLC1A1 (0.59) | — | |
| Serine SCHEMBL4455818 | 0.97 | SLC1A1 (0.59) | — | |
| Serine SCHEMBL1332181 | 0.97 | — | — | |
| Serine SCHEMBL2023739 | 0.97 | SLC1A1 (0.59) | — | |
| Serine SCHEMBL2023740 | 0.97 | SLC1A1 (0.59) | — | |
| Serine SCHEMBL6520918 | 0.97 | SLC1A1 (0.59) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0631570-A1 | COMPOUNDS | IMPERIAL CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 1995-01-04 | — | — | EP | disclosed |
| WO-1993019037-A1 | COMPOUNDS | IMPERIAL CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 1993-09-30 | — | — | WO | disclosed |